Anzeige
Meldung des Tages: US-Goldprojekt vor dem Durchbruch: Warum Investoren jetzt aufmerksam werden

Abbott Laboratories News

Aktie
WKN:  850103 ISIN:  US0028241000 US-Symbol:  ABT Branche:  Gesundheitswesen: Ausstattung u. Produkte Land:  USA
100,69 $
+0,00 $
0,00%
85,592 € 01:00:00 Uhr
Depot/Watchlist
Marktkapitalisierung *
183,47 Mrd. €
Streubesitz
18,03%
KGV
24,09
Dividende
2,11 EUR
Dividendenrendite
2,01%
Nachhaltigkeits-Score
42 %
Index-Zuordnung
S&P 500
Weiter aufwärts? Long handeln - Jetzt mit Hebel 7,49: VU49HE
Werbung

Abbott Laboratories News

24.09.25 - PR Newswire
Abbott Hosts Conference Call for Third-Quarter Earnings
Abbott Hosts Conference Call for Third-​Quarter Earnings PR Newswire
19.09.25 - PR Newswire
Abbott Declares 407th Consecutive Quarterly Dividend
Abbott Declares 407th Consecutive Quarterly Dividend PR Newswire
29.08.25 - PR Newswire
Abbott's Navitor™ TAVI System Receives CE Mark for Expanded Indication to Treat More People With Aortic Stenosis
Abbott's Navitor™ TAVI System Receives CE Mark for Expanded Indication to Treat More People With Aortic Stenosis PR Newswire
27.08.25 - PR Newswire
NYSE Content Advisory: Pre-Market update + Wall Street braces for Nvidia's earnings
NYSE Content Advisory: Pre-​Market update + Wall Street braces for Nvidia's earnings PR Newswire
27.08.25 - PR Newswire
NYSE Content Advisory: Pre-Market update + Wall Street braces for Nvidia's earnings
NYSE Content Advisory: Pre-​Market update + Wall Street braces for Nvidia's earnings PR Newswire
18.08.25 - PR Newswire
Abbott and Big Ten Conference Rally Students, Alumni, and Fans to Save Lives and Win $1 Million for Their School by Donating Blood This College Football Season
Abbott and Big Ten Conference Rally Students, Alumni, and Fans to Save Lives and Win $1 Million for Their School by Donating Blood This College Football Season PR Newswire
12.08.25 wallstreetONLINE Redaktion
Zweistelliger Pullback voraus: Die Party an den Märkten hat ein Ablaufdatum, warnt Stifel
An der Wall Street herrscht Feierlaune – doch die Investmentbank Stifel sieht ein Risiko, das die Stimmung schneller kippen lassen könnte, als vielen lieb ist. Die Investmentbank ...
31.07.25 - dpa-AFX
AKTIEN IM FOKUS: Pharma unter Druck - Trump will günstigere Preisen
Die Aussicht auf politischen Druck auf die Medikamentenpreise in den USA hat am Donnerstag die Branche belastet. Bristol Myers Squibb fielen um 5 Prozent, Eli Lilly um 3 Prozent ...
18.07.25 wallstreetONLINE Redaktion
Nach schwachen Zahlen: Beliebter Dividendenwachstumswert stürzt ab: Jetzt zugreifen?
Für die Anteile von Abbott Laboratories ging es am Donnerstag nach schwachen Zahlen um 8,5 Prozent bergab. Sollten Anlegerinnen und Anleger jetzt einsteigen? Seit 36 Jahren ...
17.07.25 - PR Newswire
Abbott Reports Second-Quarter 2025 Results
Abbott Reports Second-​Quarter 2025 Results PR Newswire
15.07.25 - PR Newswire
Artificial Intelligence Revolutionizing Early Detection of Diabetic Retinopathy Creating a Multi-Billion Dollar Revenue Opportunity
Artificial Intelligence Revolutionizing Early Detection of Diabetic Retinopathy Creating a Multi-​Billion Dollar Revenue Opportunity PR Newswire
15.07.25 - PR Newswire
Artificial Intelligence Revolutionizing Early Detection of Diabetic Retinopathy Creating a Multi-Billion Dollar Revenue Opportunity
Artificial Intelligence Revolutionizing Early Detection of Diabetic Retinopathy Creating a Multi-​Billion Dollar Revenue Opportunity PR Newswire
26.06.25 - PR Newswire
Abbott Hosts Conference Call for Second-Quarter Earnings
Abbott Hosts Conference Call for Second-​Quarter Earnings PR Newswire
20.06.25 - PR Newswire
New Research on Abbott's Healthy Food Rx Program Shows 'Food is Medicine' Approach Helps People Living With Diabetes Eat Better and Feel Healthier
New Research on Abbott's Healthy Food Rx Program Shows 'Food is Medicine' Approach Helps People Living With Diabetes Eat Better and Feel Healthier PR Newswire
13.06.25 - PR Newswire
Abbott Declares 406th Consecutive Quarterly Dividend
Abbott Declares 406th Consecutive Quarterly Dividend PR Newswire
27.05.25 - PR Newswire
Abbott Receives FDA Approval for Tendyne™, First-of-Its-Kind Device to Replace the Mitral Valve Without Open-Heart Surgery
Abbott Receives FDA Approval for Tendyne™, First-​of-Its-Kind Device to Replace the Mitral Valve Without Open-​Heart Surgery PR Newswire
15.05.25 - PR Newswire
Abbott's Libre® Technology is First Continuous Glucose Monitor Associated with Reduced Hospitalizations for Heart Complications in People with Diabetes
Abbott's Libre® Technology is First Continuous Glucose Monitor Associated with Reduced Hospitalizations for Heart Complications in People with Diabetes PR Newswire
07.05.25 - PR Newswire
Abbott and Real Madrid Kick Off Search to Empower Young Soccer Talent
Abbott and Real Madrid Kick Off Search to Empower Young Soccer Talent PR Newswire
01.05.25 - PR Newswire
MotoAmerica Becomes First Sports Organization to Use Abbott's Rapid Blood Test for Concussion Evaluation On-site at Races
MotoAmerica Becomes First Sports Organization to Use Abbott's Rapid Blood Test for Concussion Evaluation On-site at Races PR Newswire
29.04.25 - PR Newswire
Abbott Integrates Libre's Data with Epic's Electronic Health Record System, Providing Healthcare Professionals Seamless Glucose Monitoring Information
Abbott Integrates Libre's Data with Epic's Electronic Health Record System, Providing Healthcare Professionals Seamless Glucose Monitoring Information PR Newswire

Newssuche

Videos

newspaper
07.04.26 +5,47%
Technical Trading: DAX Long kurzfristig
DAX Long Typ: Turbo Open End WKN: VJ9H40 Hebel:11,30 Laufzeit: OpenEnd Einstieg: Market ... Mehr »